Analyzing Orthofix Medical (NASDAQ:OFIX) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS)

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) and Orthofix Medical (NASDAQ:OFIX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, institutional ownership, dividends, valuation and risk.

Analyst Recommendations

This is a summary of current ratings and target prices for Senseonics Holdings, Inc. Common Stock and Orthofix Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Senseonics Holdings, Inc. Common Stock	1	1	4	0	2.50
Orthofix Medical	1	1	3	0	2.40

Senseonics Holdings, Inc. Common Stock currently has a consensus target price of $17.20, suggesting a potential upside of 78.85%. Orthofix Medical has a consensus target price of $14.75, suggesting a potential upside of 52.61%. Given Senseonics Holdings, Inc. Common Stock’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Senseonics Holdings, Inc. Common Stock is more favorable than Orthofix Medical.

Valuation & Earnings

This table compares Senseonics Holdings, Inc. Common Stock and Orthofix Medical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Senseonics Holdings, Inc. Common Stock	$35.26 million	11.40	-$69.11 million	($2.23)	-4.31
Orthofix Medical	$822.31 million	0.48	-$92.19 million	($1.54)	-6.28

Senseonics Holdings, Inc. Common Stock has higher earnings, but lower revenue than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Senseonics Holdings, Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Institutional & Insider Ownership

12.4% of Senseonics Holdings, Inc. Common Stock shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 4.7% of Senseonics Holdings, Inc. Common Stock shares are owned by company insiders. Comparatively, 2.7% of Orthofix Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Risk and Volatility

Senseonics Holdings, Inc. Common Stock has a beta of 1.01, meaning that its stock price is 1% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 0.68, meaning that its stock price is 32% less volatile than the S&P 500.

Profitability

This table compares Senseonics Holdings, Inc. Common Stock and Orthofix Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Senseonics Holdings, Inc. Common Stock	-225.09%	-165.80%	-80.14%
Orthofix Medical	-7.41%	-14.05%	-7.17%

Summary

Senseonics Holdings, Inc. Common Stock beats Orthofix Medical on 8 of the 14 factors compared between the two stocks.

About Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company’s products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

About Orthofix Medical

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.